Markets exhale as Novo Nordisk withdraws from Metsera bidding war
Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s shares slipped but Novo Nordisk’s stock rose on news it was bowing out of the race.
https://anessoft.com/blog/ar/macron-evoque-une-possible-reprise-du-dialogue-avec-vladimir-poutine
Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s shares slipped but Novo Nordisk’s stock rose on news it was bowing out of the race.
What's Your Reaction?
